Wave Issue 0301 1/17/03 Article 5-03

***Motorola, Avaya, and Proxim Collaborate on Wireless
Communications
(January 14)

Motorola Inc., Avaya Inc., and Proxim Corporation today announced
they will collaborate on the creation and deployment of converged
cellular, Wireless Local Area Networking (WLAN), and Internet
Protocol (IP) Telephony solutions. These solutions will be
enabled by an array of new products including a Wi-Fi/cellular
dual-system phone from Motorola, Session Initiation Protocol
(SIP)-enabled IP Telephony software from Avaya, and voice enabled
WLAN infrastructure from Proxim.

The jointly-developed, standards-based solutions will support
contiguous voice and data service to users across enterprise
networks, public cellular networks, and public hotspot WLANs,
based on 802.11 technology (Wi-Fi). The partners believe the
convergence of these technologies will enable businesses to gain
cost savings, user efficiencies, and enhanced communications
capabilities.

Cost-savings can be achieved through reduced network management
expenses, lower usage charges and device consolidation. User
efficiencies can result from increased accessibility to the
business network and greater mobility, through wireless access to
business networks, applications, and information. Enhanced
communications capabilities can include on-demand conference
calling, and speech access to business applications such as
email, calendars and corporate directories.

The IP Telephony application is enabled by Avaya MultiVantage
Software. Motorola will create network Mobility Management
components that control the hand-off between local (WLAN) and
cellular networks. Proxim will provide voice-enabled Wi-Fi WLAN
infrastructure, quality of service software, and centralized
management systems to facilitate hand-offs between access points.

Voice-enabled Wi-Fi WLAN infrastructure from Proxim and SIP-
enabled communications applications from Avaya are expected to be
made available early in 2003, establishing a ready base for
converged communications. Trials of the joint solution are
expected to begin in the second half of 2003.